Metropolis Network Expansion and Revenue Growth Strategy

9MFY24 Performance Snapshot 3. & گاه 9MFY24 Key Highlights METROPOLIS The Pathology Specialist Total Revenue Rs. 877 Crores 1% YoY Core Business* Revenue Rs. 858 Crores 13% YoY Core Business* Patient Vol. 8.62 Mn 9% YoY Core Business* Test Vol. 17.4 Mn 9% YoY Core Business* RPP Rs. 996 3% YoY Core Business* RPT Rs 493 3% YoY *Core business excludes revenue for Covid & Covid allied and PPP Contracts (incl. Hi-tech) EBITDA Margin (Before CSR & ESOP) 24.3% Reported EBITDA Margin^ 23.4% ^0.7% impact on account of one-time provision for doubtful debt 5

View entire presentation